Heart Failure POC & LOC Devices Market Size Is Estimated To Reach $129.69 Million By 2025

The global heart failure POC & LOC devices market size is expected to reach USD 129.69 million by 2025 and is projected to grow at a CAGR of 16.2%, according to a new report by Grand View Research, Inc. A paradigm shift in diagnostic sectors from late-stage disease detection to early identification of diseases as a viable strategy to curb rising healthcare costs has driven the market. This shift has led to the development of disposable and low-cost LOC devices that integrate various sensors and associated accessories in a single space for detection of the cardiac biomarkers from a single specimen to evaluate the risk of having a heart attack.

Furthermore, the development of predictive modeling techniques-based decision support software to analyze the data measured by the LOC assays to enable therapy monitoring is one of the key market drivers. Also, ongoing studies on the application of saliva-based nano-biochip tests for measuring myocardial infarction is driving organic revenue growth.

POC testing exhibits potential savings across various settings, including hospitals, general practice, and remote areas. In the U.S., the employment of POC devices resulted in a 20% decrease in hospital admissions to the chest pain unit, resulting in substantial savings in time and costs.

In the cardiac observation unit (U.S.), the implementation of POC troponin testing helped reduce hospital stays, decrease admission rates, and remove the need for multiple costly procedures, resulting in 25% cost saving per patient. Furthermore, the integration of smartphones and apps in POC diagnostics for managing the cardiac health of an individual is one of the significant innovations in Heart Failure POC & LOC Devices market.

Full Research Report On Heart Failure POC & LOC Devices Market Visit Here: https://www.grandviewresearch.com/industry-analysis/heart-failure-poc-loc-devices-market

Further key findings from the report suggest:

• Proteomic analysis includes products that test protein markers, such as troponin, myoglobin, and Creatine Kinase MB Isoenzyme (CK-MB)
• This segment accounted for the leading revenue share, as most of the currently available products are based on testing of protein markers
• Increasing implementation of microfluidic LOC technology for assessing putative biomarkers has led to the largest revenue share of this technology
• Microfluidic technologyhas been implemented for various biological applications, such as immunohybridization techniques, enzymatic assays, PCR, and others
• Clinics that include physician’s office, pharmacy & retail clinics, urgent care clinics, and non-practice clinics are the key revenue generating end-users
• A high usage rate of POC devices by general practitioners for rapid investigation, deciding early treatment, timely referral, and less uncertainty for patients has driven the revenue growth through clinics
• The U.S. dominated the global Heart Failure POC & LOC devices market owing to the presence of a substantial number of primary care clinics that are deploying POC cardiac marker test as a measure for early detection of heart failure
• Expanding urbanization and increasing geriatric population underpin the demand for robust and improved healthcare services such as POC diagnostics for routine cardiac health monitoring in Asian countries
• Moreover, initiatives are undertaken for training young healthcare personnel about POC cardiac troponin T/cardiac troponin I biomarkers
• This, in turn, is anticipated to result in the surging adoption rate of POC devices in Asian countries
• Abbott, Siemens Healthineers, Danahar, and F. Hoffmann-La Roche Ltd are some key participants operating in the space
• Companies are engaged in mergers and acquisitions of emerging players. Acquisition of Alere by Abbott, Beckman Coulter, Inc by Danahar, and Accriva Diagnostics by Instrumentation Laboratory are some examples of acquisitions in this market

Request a Sample Copy of the Report @ https://www.grandviewresearch.com/industry-analysis/heart-failure-poc-loc-devices-market/request/rs1

Grand View Research has segmented the heart failure POC & LOC devices market on the basis of test type, technology, end-use, and regions:

Test Type Outlook (Revenue, USD Million, 2014 - 2025)

• Proteomic Testing
• Metabolomic Testing
• Genomic Testing

Technology Outlook (Revenue, USD Million, 2014 - 2025)

• Microfluidics
• Array-based Systems
• Others

End-use Outlook (Revenue, USD Million, 2014 - 2025)

• Clinics
• Hospitals
• Home
• Assisted Living Healthcare Facilities
• Laboratory

Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• Japan
• China
• Latin America
• Brazil
• Middle East and Africa (MEA)
• South Africa
• Saudi Arabia

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

 

CAD CAM Dental Milling Machine Market Growth & Latest Trends

The global CAD CAM dental milling machine market size is expected to reach USD 3.1 billion by 2026, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 9.6%. Increasing number of dental disorders, technological advancements in dental milling machines, and rising expenditure for the treatment of oral diseases are driving growth.

Developments and upgrades in technologies pertaining to CAD/CAM dental milling systems are impelling demand. The developments have resulted in reduced time and requirement for human resources to operate these dental milling machines.

In the U.S., nearly 50% of the total number of dental labs use CAD/CAM, while over 80% of larger labs employ complete CADCAM systems, including milling systems & scanners, among others.Such high adoption of the CAD/CAM software is expected to fuel CAD/CAM dental milling machine market growth. Moreover, advancements in digital dentistry and increasing demand for customized prosthetics & intraoral scanners are likely to contribute to growth.

Full Research Report On CAD CAM Dental Milling Machine Market Visit Here: https://www.grandviewresearch.com/industry-analysis/cad-cam-dental-milling-machine-market

CAD CAM Dental Milling Machine Market Report Highlights

• The 4-axis machines segment is expected to hold a larger share of the market during the forecast period owing to the cost-effectiveness of these machines
• 4-axis machines can be used for milling dental materials such as bridges; inlays, onlays, & crowns; copings; and custom abutments
• The benchtop segment is expected to grow at a significant rate during the forecast period owing to the sturdy design and durability of these dental milling machines, which make them ideal for complex tasks, thereby boosting their demand in the market
• Dental CAD/CAM milling machines at an in-office setting comprise a scanner & a personal computer and are as effective as laboratory machines
• The standalone segment is expected to grow at a steady pace owing to the high efficiency of these equipment to mill the toughest materials in bulk
• Asia Pacific is expected to grow at the highest rate during the forecast period due to the rising geriatric population and growing awareness among end users about enhancements in the CAD/CAM machine
• Some of the key players are Amann Girrbach, Dentsply Sirona, Planmeca OY, Ivoclar Vivadent, 3M Company, Straumann, Zimmer, Dentium, Roland DGA Corporation, and DATRON.

Request a Sample Copy of the Report @ https://www.grandviewresearch.com/industry-analysis/cad-cam-dental-milling-machine-market/request/rs1

CAD CAM Dental Milling Machine Market Segmentation

Grand View Research, Inc. has segmented the global CAD CAM dental milling machine market on the basis of axis type, size, and region:

CAD/CAM Dental Milling Machine Axis Type Outlook (Revenue, USD Million, 2015 - 2026)

• 4-axis machines
• 5-axis machines

CAD/CAM Dental Milling Machine Size Outlook (Revenue, USD Million, 2015 - 2026)

• Tabletop
• Benchtop
• Standalone

CAD/CAM Dental Milling Machine Regional Outlook (Revenue, USD Million, 2015 - 2026)

• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• France
• Spain
• Italy
• Asia Pacific
• India
• Japan
• China
• Thailand
• South Korea
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

 

U.S. Freestanding Emergency Department Market Size Is Estimated To Reach $5.0 Billion By 2027

The U.S. freestanding emergency department market size is expected to reach USD 5.0 billion by 2027, registering around 5.3% CAGR over the forecast period, according to a new report by Grand View Research, Inc. Convenience care represents a spectrum of care delivery models including retail clinics, urgent care centers, and freestanding emergency departments (FSEDs). These departments represent a budding opportunity within healthcare services space. Growing geriatric population is contributing to the increasing demand for freestanding emergency departments, as the elderly often require emergency care. In addition, FSEDs have no or short waiting times for treatments as compared to the emergency departments. FSEDs are often preferred as they are less crowded. These departments primarily cater to urban and suburban patients with insurance coverage or self-pay. Moreover, medical conditions of patients visiting FSEDs are less acute than the ones visiting emergency departments.

The growth of the freestanding ED segment opens up opportunities for independent companies such as Adeptus and hospitals such as HCA Healthcare, Inc. (HCA); Tenet Healthcare Corporation (THC); and Community Health Systems, Inc. (CYH). As the need for emergency room services grows, independent providers such as Adeptus Health and numerous private equity-backed companies are contributing actively to the industry. Also, the large acute care hospitals such as HCA, and others address this demand through the buildout of freestanding emergency rooms.

Full Research Report On U.S. Freestanding Emergency Department Market Visit Here: https://www.grandviewresearch.com/industry-analysis/us-freestanding-emergency-department-market

U.S. Freestanding Emergency Department Market Report Highlights

• In 2019, Hospital-based off-campus emergency department (OCED) held the largest share in the ownership segment of the U.S. FSED market and is expected to witness lucrative growth during the forecast period. This was attributed to the overcrowding of the hospital emergency department, and availability of high reimbursement for the treatment at OCED when compared with independent freestanding emergency department (IFSED), where no reimbursement is available
• In 2019, Emergency department (ED) held the largest share in the service segment owing to a wide variety of services being provided for immediate care. It includes common medical services, such as treatment for stomach and abdominal pain, fever, headache, cough, back symptoms, and shortness of breath among others
• The imaging service segment is expected to witness the highest growth during the forecast period. Majority of FSEDs offer basic imaging services, such as X-ray, ultrasound, and Computed Tomography (CT) scans. Freestanding emergency departments are either large facilities serving as many as 100 patients per day or small facilities serving 20 or fewer patients per day. Larger FSEDs can also offer MRI and primary care
• Some of the key players operating in the U.S. freestanding emergency department market are Adeptus Health Inc.; Tenet Healthcare Corporation; Universal Health Services, Inc.; HCA Healthcare, Inc.; Community Health Systems, Inc.; Ascension Health; Legacy Lifepoint Health, Inc.; Ardent Health Services; and Emerus

Request a Sample Copy of the Report @ https://www.grandviewresearch.com/industry-analysis/us-freestanding-emergency-department-market/request/rs1

U.S. Freestanding Emergency Department Market Segmentation

Grand View Research has segmented the U.S. freestanding emergency department market based on ownership and service:

U.S. Freestanding Emergency Department (FSED) Ownership Outlook (Revenue, USD Million, 2016 - 2027)

• Off-Campus Emergency Department (OCED)
• Independent Freestanding Emergency Department (IFSED)

U.S. Freestanding Emergency Department (FSED) Service Outlook (Revenue, USD Million, 2016 - 2027)

• Emergency Department (ED) Service
• Imaging Service
• Laboratory Service

U.S. Freestanding Emergency Department (FSED) Region Outlook (Revenue, USD Million, 2016 - 2027)

• U.S.

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

 

Patch Based Wound Healing Products Market Size Is Projected To Reach $1.52 Billion By 2026

The global patch based wound healing products market size is expected to reach USD 1.51 billion by 2026, according to a new report by Grand View Research, Inc. It is projected to register a CAGR of 4.2% during the forecast period. Factors such as increasing prevalence of acute and chronic wounds, number of surgical procedures, incidence of road accidents, and demand for rapid wound healing products are expected to propel the market growth.

Increasing cases of chronic and acute wounds across the globe is anticipated to be the major growth driver for the market. As per a journal published by the ScienceDirect in 2018, prevalence of non-healing chronic wounds in the developed countries is around 1.0 to 2.0% of the population. Adoption of unhealthy and sedentary lifestyles, alcohol consumption, and smoking are some of the major factors contributing to the rise in prevalence of non-communicable diseases.

According to the National Diabetes Statistic Report, 2017, published by the Centers for Disease Control and Prevention (CDC), more than 100 million people in U.S. were living with diabetes or prediabetes in the same year. According to a report published by the American Diabetes Association in 2018, the annual incidence of diabetic foot ulcer was around 2.0% in most Western countries. Rising prevalence of acute wounds across the globe is anticipated to drive the patch based wound healing products market. As per the World Health Organization (WHO), over 1,000,000 people are registered, annually, as moderately or severely burnt. Rising incidence of burns is also anticipated to propel the product demand over the forecast period.

Full Research Report On Patch Based Wound Healing Products Market Visit Here: https://www.grandviewresearch.com/industry-analysis/patch-based-wound-healing-products-market

Patch Based Wound Healing Products Market Report Highlights

• In terms of revenue, acute wounds segment held the largest market share in 2018 owing to the rising cases of road accidents and burn cases across the globe
• The collagen based wound healing products held the largest market share in 2018 owing to wide range of product application for the treatment of various types of wounds
• Asia Pacific patch based wound healing products market is expected to witness the fastest CAGR over the forecast period owing to the huge untapped market potential and rising number of road accidents
• Few of the prominent market players are Johnson & Johnson Services, Inc.; Smith & Nephew plc; Mölnlycke Health Care; Coloplast; 3M; and B. Braun Melsungen AG

Request a Sample Copy of the Report @ https://www.grandviewresearch.com/industry-analysis/patch-based-wound-healing-products-market/request/rs1

Patch Based Wound Healing Products Market Segmentation

Grand View Research has segmented the global patch based wound healing products market report on the basis of formulation, application, and region:

Patch Based Wound Healing Products Formulation Outlook (Revenue, USD Million, 2015 - 2026)

• Povidone-iodine
• Silver
• Collagen
• Others

Patch Based Wound Healing Products Application Outlook (Revenue, USD Million, 2015 - 2026)

• Chronic Wound
• Acute Wound

Patch Based Wound Healing Products Regional Outlook (Revenue, USD Million, 2015 - 2026)

• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• Asia-Pacific
• Japan
• China
• Latin America
• Brazil
• Mexico
• MEA
• South Africa
• Saudi Arabia

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

 

Open MRI Systems Market Size, Future Growth Insights And Latest Trends By 2026

The global open MRI systems market size is expected to reach USD 1.4 billion by 2026, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 6.4%. Increasing demand for high strength open MRI systems is expected to drive growth during the forecast period.

Changing lifestyle and increasing prevalence of age-associated chronic conditions including cancers and neurological disorders are among the factors expected to boost the demand for safer and accurate diagnostic imaging devices. Open MRIs are specifically designed to provide comfort to patients, especially children and obese patients.

Limited number of high strength open MRI systems and large number of ongoing studies are expected to widen the scope for growth of the market over the forecast period. Launch of Oasis open MRI 1.2T system by Hitachi and rapid geographic expansion of the company are likely to contribute to the high demand for advanced open MRIs in developed and developing regions.

Increasing number of strategic initiatives such as development of advanced software for open MRI systems and patient-friendly devices with less noise is among the factors expected to propel market growth. Moreover, rising awareness about preventive diagnostics and growing medical tourism in developing regions are some of the factors expected to aid in growth.

Full Research Report On Open MRI Systems Market Visit Here: https://www.grandviewresearch.com/industry-analysis/open-mri-systems-market

Open MRI Systems Market Report Highlights

• High field strength open MRI systems segment is expected to grow at the fastest CAGR as these systems are effective in capturing detailed images
• Low field strength open MRI systems segment held the largest market share in 2018 mainly owing to limitations of open structure in integrating high strength magnets
• On the basis of application, the brain segment held the largest open MRI systems market share in 2018 owing to growing geriatric population and high prevalence of neurodegenerative diseases
• The breast segment, based on application, is expected to grow at a lucrative rate mainly due to growing incidence of breast cancer and rising demand for early diagnosis
• Asia Pacific is anticipated to witness the fastest growth over the forecast period due to factors such as rapidly advancing healthcare facilities, increasing disposable income, rising awareness about preventive diagnostics, and growing economies
• Major players in the industry are focusing on technological advancements to enhance images and reduce the time of diagnosis

Request a Sample Copy of the Report @ https://www.grandviewresearch.com/industry-analysis/open-mri-systems-market/request/rs1

Open MRI Systems Market Segmentation

Grand View Research has segmented the global open MRI systems market on the basis of field strength, application, and regions:

Open MRI Systems Field Strength Outlook (Volume in ‘000 Units; Revenue, USD Million, 2015 - 2026)

• Low
• Medium
• High

Open MRI Systems Application Outlook (Volume in ‘000 Units; Revenue, USD Million, 2015 - 2026)

• Brain
• Spine
• Abdominal
• Breast
• Cardiac
• Others

Open MRI Systems Regional Outlook (Volume in ‘000 Units; Revenue, USD Million, 2015 - 2026)

• North America
• U.S.
• Canada
• Europe
• Germany
• U.K.
• France
• Italy
• Spain
• Asia Pacific
• China
• Japan
• India
• Thailand
• South Korea
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

 

Peptide Synthesis Market Size, Future Growth Analysis And Trends

The global peptide synthesis market size is expected to reach USD 1,011.99 million by 2026 growing at a CAGR of 13.0%, according to a new report by Grand View Research, Inc. Significant research and innovation targeted towards the development of peptide therapeutics is set to boost the market growth in the near future. Additionally, increasing advancements in the peptide synthesis technologies is expected to offer profitable opportunities for the companies operating in the market.

A surge in the demand for custom peptide synthesis has been observed in the recent years; several companies operating in this industry offer products and services associated with custom peptide synthesis. For instance, a UK based company namely, Almac Group offers peptide synthesis suitable for research use. Constantly growing demand and evolving market landscape for custom peptides is set to offer lucrative opportunities for the market growth. The suppliers are expanding their production capacity to suffice the increasing demand for high quality peptides across research and therapeutics areas.

Rising focus of the pharmaceutical companies towards the development of novel biologics and shifting the peptide drugs from the pipeline stage to commercial scale further strengthens the market growth. Increase in the number of research activities performed on exploring the potential of high-quality peptides and peptide libraries in the development of vaccines and biomarker discovery heavily contributes to the revenue generated by the global peptide synthesis market. Moreover, introduction of modified peptides (GMP peptides) that possess enhanced stability and pharmacokinetic properties in the market is expected to maintain the double-digit market growth throughout the forecast period.

Therapeutic peptide development has witnessed remarkable growth in the recent years, this is further driven by significant increase in the patient pool suffering from cardiovascular and metabolic diseases. This has propelled the discovery of bioactive peptides exponentially which further drives the market demand.

Full Research Report On Peptide Synthesis Market Visit Here: https://www.grandviewresearch.com/industry-analysis/peptide-synthesis-market

Further key findings from the study suggest:

• Reagents & consumables accounted for the highest revenue generated in 2018 and is anticipated to maintain this trend throughout the forecast period.
• Peptide synthesis equipment has registered fastest growth during the forecast period.
• Peptide synthesizers segment serves to be a major contributor to the revenue generated by equipment in the global market and is anticipated to grow at highest CAGR of 13.91% from 2019-2026 among other peptide synthesis equipment.
• Liquid phase peptide synthesis (LPPS) technology dominated the peptide synthesis market in 2018 and is expected to continue this dominance throughout the forecast period.
• Therapeutic peptide synthesis has garnered largest share in the market in 2018 and is anticipated to maintain this trend throughout the forecast period.
• North America region has generated highest revenue in 2018 and is expected to maintain this dominance throughout the forecast period; sufficient presence of skilled professionals along with the strong network of peptide synthesis manufacturers is attributive to this region’s dominance in the global market.
• APAC is expected to offer lucrative opportunities for the market expansion, attributed to rising focus on the development of peptide therapeutics.
• Large patient pool for cardiovascular and metabolic diseases in the APAC region has significantly contributed to the revenue generated, contributing to the highest CAGR registered during the forecast period.
• Some of the key market participants are Genscript Biotech, Merck KGaA, Bachem Holdings, Biotage, CEM Corporation, Thermo Fisher, and Novo Nordisk among others.

Request a Sample Copy of the Report @ https://www.grandviewresearch.com/industry-analysis/peptide-synthesis-market/request/rs1

Grand View Research has segmented the global peptide synthesis market on the basis of product, technology, application, end-use, and region:

Peptide Synthesis Product Outlook (Revenue, USD Million, 2014 - 2026)

• Equipment
• Peptide Synthesizers
• Lyophilizers
• Chromatography Equipment
• Others
• Reagents & Consumables
• Other

Peptide Synthesis Technology Outlook (Revenue, USD Million, 2014 - 2026)

• Solid Phase Peptide Synthesis (SPPS)
• Liquid Phase Peptide Synthesis (LPPS)
• Hybrid Technology

Peptide Synthesis Application Outlook (Revenue, USD Million, 2014 - 2026)

• Therapeutics
• Cancer
• Metabolic
• Cardiovascular Disorder
• Respiratory
• GIT (Gastrointestinal Disorders)
• Infectious Diseases
• Pain
• Dermatology
• CNS
• Renal
• Others
• Diagnosis
• Research

Peptide Synthesis End-use Outlook (Revenue, USD Million, 2014 - 2026)

• Pharmaceutical & Biotechnology Companies
• Contract Development & Manufacturing Organization/Contract Research Organization
• Academic & Research Institutes

Peptide Synthesis Regional Outlook (Revenue, USD Million, 2014 - 2026)

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Italy
• Asia Pacific
• Japan
• China
• India
• Australia
• Latin America
• Brazil
• Mexico
• MEA
• South Africa
• Saudi Arabia

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com